What is Charles River Laboratories International Revenue per Share?
Charles River Laboratories International's revenue per share for the
three
months ended in Dec. 2023 was $19.75.
Charles River Laboratories International's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was $80.25.
Warning Sign:
Charles River Laboratories International Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of Charles River Laboratories International was 3.60% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 11.60% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 12.40% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 13.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
CRL'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -17.6 Med: 9.5 Max: 17.3
Current: 11.6
During the past 13 years, Charles River Laboratories International's highest 3-Year average Revenue Per Share Growth Rate was 17.30% per year. The lowest was -17.60% per year. And the median was 9.50% per year.
CRL's 3-Year Revenue Growth Rate is ranked better than 60.89% of 202
companies
in the Medical Diagnostics & Research industry
Industry Median: 8.6
vs CRL: 11.60
Charles River Laboratories International Revenue per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Charles River Laboratories International Revenue per Share Chart
Charles River Laboratories International Annual Data
Competitive Comparison of Charles River Laboratories International's Revenue per Share
For the Diagnostics & Research subindustry, Charles River Laboratories International's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Charles River Laboratories International's PS Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's PS Ratio distribution charts can be found below:
* The bar in red indicates where Charles River Laboratories International's PS Ratio falls into.
Charles River Laboratories International Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $80.25
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International (NYSE:CRL) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Charles River Laboratories International Revenue per Share Related Terms
Thank you for viewing the detailed overview of Charles River Laboratories International's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Charles River Laboratories International (Charles River Laboratories International) Business Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CRL has been successfully added to your 